These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 28827151)

  • 21. Stem cells in kidney diseases.
    Soler MJ; José Tomas OP
    J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research and clinical applications regarding endothelial progenitor cell transplantation].
    Tan K; Sun X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 39(11):1211-6. PubMed ID: 25432379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise review: Circulating endothelial progenitor cells for vascular medicine.
    Asahara T; Kawamoto A; Masuda H
    Stem Cells; 2011 Nov; 29(11):1650-5. PubMed ID: 21948649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial progenitor cells participation in cardiovascular and kidney diseases: a systematic review.
    Kiewisz J; Kaczmarek MM; Pawlowska A; Kmiec Z; Stompor T
    Acta Biochim Pol; 2016; 63(3):475-82. PubMed ID: 27474403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
    Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
    Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial progenitor cells for regeneration.
    Masuda H; Kalka C; Asahara T
    Hum Cell; 2000 Dec; 13(4):153-60. PubMed ID: 11329932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow-derived endothelial progenitor cells: isolation and characterization for myocardial repair.
    Ii M
    Methods Mol Biol; 2010; 660():9-27. PubMed ID: 20680810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The State of Art of Regenerative Therapy in Cardiovascular Ischemic Disease: Biology, Signaling Pathways, and Epigenetics of Endothelial Progenitor Cells.
    Perrotta F; Perna A; Komici K; Nigro E; Mollica M; D'Agnano V; De Luca A; Guerra G
    Cells; 2020 Aug; 9(8):. PubMed ID: 32796767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.
    Dzau VJ; Gnecchi M; Pachori AS; Morello F; Melo LG
    Hypertension; 2005 Jul; 46(1):7-18. PubMed ID: 15956118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of myocardial regeneration.
    Hosoda T; Kajstura J; Leri A; Anversa P
    Circ J; 2010 Jan; 74(1):13-7. PubMed ID: 19920358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial progenitor cells for vascular regeneration.
    Asahara T; Isner JM
    J Hematother Stem Cell Res; 2002 Apr; 11(2):171-8. PubMed ID: 11983091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial progenitor cells and cardiovascular cell-based therapies.
    Mund JA; Ingram DA; Yoder MC; Case J
    Cytotherapy; 2009; 11(2):103-13. PubMed ID: 19241233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular repair by endothelial progenitor cells.
    Zampetaki A; Kirton JP; Xu Q
    Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models.
    Haider KH; Aziz S; Al-Reshidi MA
    Regen Med; 2017 Dec; 12(8):969-982. PubMed ID: 29215316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial progenitor cell-based neovascularization: implications for therapy.
    Krenning G; van Luyn MJ; Harmsen MC
    Trends Mol Med; 2009 Apr; 15(4):180-9. PubMed ID: 19303359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
    Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
    Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
    Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
    Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway.
    Everaert BR; Van Craenenbroeck EM; Hoymans VY; Haine SE; Van Nassauw L; Conraads VM; Timmermans JP; Vrints CJ
    Int J Cardiol; 2010 Oct; 144(3):350-66. PubMed ID: 20444511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
    Sen S; McDonald SP; Coates PT; Bonder CS
    Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.